About

Gary Calderwood is a Product Manager at SHL, leading efforts on the development and lifecycle management of the company’s device technologies, from concept through to production. In his role, he specialises in bridging the gap between the technical, strategic and commercial needs of SHL’s specialty autoinjectors portfolio. Prior to his current role, Mr Calderwood was a Senior Design Engineer at SHL, where he led and assisted in the exploration and development of several autoinjector devices within the company’s expanding product portfolio. Mr Calderwood possesses a higher degree in Medical Design Compliance in addition to a Bachelor of Science in Product Design. He has more than a decade of professional experience in a broad range of design-related roles, with a focus on product development.

Contributions

SHL autoinjectors Maggie 3.0 mL and 5.0 mL

INJECTION

ENLARGING THE VOLUME OF AUTOINJECTORS: TRAVERSING INJECTION BOUNDARIES

Gary Calderwood, Raluca Ganea and Gene Rhode Fuensalida Pantig review how the parenteral space has transformed over the past decade and reports how the company’s portfolio of autoinjector technologies has evolved to deliver subcutaneous parenteral drugs of varying formulations, including higher administration volumes.